TMEPAI regulates EMT in lung cancer cells by modulating the ROS and IRS-1 signaling pathways

Carcinogenesis

Volumn 34, Issue 8, 2013, Pages 1764-1772

  Hu, Ying ^a   He, Kai ^a   Wang, Dongmei ^a   Yuan, Xinwang ^a   Liu, Yi ^a   Ji, Hongbin ^a   Song, Jianguo ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HYDROGEN PEROXIDE; INSULIN RECEPTOR SUBSTRATE 1; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; REACTIVE OXYGEN METABOLITE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMALL INTERFERING RNA; TRANSMEMBRANE PROTEIN ANDROGEN INDUCED 1; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HEAVY CHAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84881505855     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt132     Document Type: Article

References (39)

1. Thiery, J.P. et al. (2009) Epithelial-mesenchymal transitions in development and disease. Cell, 139, 871-890.
2. Yang, J., et al. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell, 14, 818-829.
3. Cannito, S., et al. (2010) Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid. Redox Signal., 12, 1383-1430.
4. Scheel, C., et al. (2011) Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int. J. Cancer, 129, 2310-2314.
5. Tiwari, N., et al. (2012) EMT as the ultimate survival mechanism of cancer cells. Semin. Cancer Biol., 22, 194-207.
6. Battula, V.L., et al. (2010) Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells, 28, 1435-1445.
7. Ansieau, S., et al. (2008) Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell, 14, 79-89.
8. Weinberg, R.A. (2008) Twisted epithelial-mesenchymal transition blocks senescence. Nat. Cell Biol., 10, 1021-1023.
9. Liu, Y., et al. (2008) Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development (Cambridge, England), 135, 579-588.
10. Liu, M., et al. (2009) p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc. Natl Acad. Sci. USA, 106, 19035-19039.
11. Cano, A., et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol., 2, 76-83.
12. Janda, E., et al. (2006) Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin. Oncogene, 25, 7117-7130.
13. Lu, X., et al. (2010) Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin. Cancer Res., 16, 5928-5935.
14. Giannoni, E., et al. (2012) EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid. Redox Signal., 16, 1248-1263.
15. Pan, X., et al. (2009) Nitric oxide suppresses transforming growth factor- beta1-induced epithelial-to-mesenchymal transition and apoptosis in mouse hepatocytes. Hepatology, 50, 1577-1587.
16. Ziech, D., et al. (2011) Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat. Res., 711, 167-173.
17. Patten, D.A., et al. (2010) Reactive oxygen species: stuck in the middle of neurodegeneration. J. Alzheimers. Dis., 20 (Suppl. 2), S357-S367.
18. Rains, J.L., et al. (2011) Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med., 50, 567-575.
19. Zhang, K.H., et al. (2009) Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition. Cancer Res., 69, 5340-5348.
20. Wang, X., et al. (2010) AMP-activated protein kinase is required for induction of apoptosis and epithelial-to-mesenchymal transition. Cell. Signal., 22, 1790-1797.
21. Shi, J., et al. (2009) Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition. Cancer Res., 69, 7180-7187.
22. Tang, Y., et al. (2011) FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers. Cell Res., 21, 316-326.
23. Giannini, G., et al. (2003) EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer. Mol. Carcinog., 38, 188-200.
24. Xu, L.L., et al. (2000) A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. Genomics, 66, 257-263.
25. Brunschwig, E.B., et al. (2003) PMEPA1, a transforming growth factor-betainduced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Cancer Res., 63, 1568-1575.
26. Singha, P.K., et al. (2010) Transforming growth factor-beta (TGF-beta)- inducible gene TMEPAI converts TGF-beta from a tumor suppressor to a tumor promoter in breast cancer. Cancer Res., 70, 6377-6383.
27. Watanabe, Y., et al. (2010) TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling. Mol. Cell, 37, 123-134.
28. Shirai, Y., et al. (1992) Elevated levels of plasma transforming growth factor- beta in patients with hepatocellular carcinoma. Jpn. J. Cancer Res., 83, 676-679.
29. Hartmann, M.C., et al. (2011) Relationship between CCL5 and transforming growth factor-β1 (TGFβ1) in breast cancer. Eur. J. Cancer, 47, 1669-1675.
30. Peinado, H., et al. (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer, 7, 415-428.
31. Shih, J.Y., et al. (2011) The EMT regulator slug and lung carcinogenesis. Carcinogenesis, 32, 1299-1304.
32. Micalizzi, D.S., et al. (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J. Mammary Gland Biol., 15, 117-134.
33. Torres, M. (2003) Mitogen-activated protein kinase pathways in redox signaling. Front. Biosci., 8, d369-d391.
34. Matsuzawa, A., et al. (2005) Stress-responsive protein kinases in redoxregulated apoptosis signaling. Antioxid. Redox Signal., 7, 472-481.
35. Martindale, J.L., et al. (2002) Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol., 192, 1-15.
36. Morgan, M.J., et al. (2011) Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res., 21, 103-115.
37. Leslie, N.R. (2006) The redox regulation of PI 3-kinase-dependent signaling. Antioxid. Redox Sign., 8, 1765-1774.
38. Xu, L.L., et al. (2003) PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. Cancer Res., 63, 4299-4304.
39. Li, H., et al. (2008) A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. J. Biol. Chem., 283, 28988-28995.